全文获取类型
收费全文 | 617篇 |
免费 | 47篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 44篇 |
妇产科学 | 19篇 |
基础医学 | 76篇 |
口腔科学 | 11篇 |
临床医学 | 59篇 |
内科学 | 107篇 |
皮肤病学 | 29篇 |
神经病学 | 26篇 |
特种医学 | 95篇 |
外科学 | 68篇 |
综合类 | 23篇 |
预防医学 | 30篇 |
眼科学 | 7篇 |
药学 | 34篇 |
中国医学 | 1篇 |
肿瘤学 | 31篇 |
出版年
2021年 | 4篇 |
2020年 | 3篇 |
2019年 | 4篇 |
2018年 | 2篇 |
2017年 | 6篇 |
2016年 | 6篇 |
2015年 | 8篇 |
2014年 | 17篇 |
2013年 | 29篇 |
2012年 | 11篇 |
2011年 | 24篇 |
2010年 | 24篇 |
2009年 | 28篇 |
2008年 | 22篇 |
2007年 | 20篇 |
2006年 | 18篇 |
2005年 | 23篇 |
2004年 | 16篇 |
2003年 | 18篇 |
2002年 | 14篇 |
2001年 | 10篇 |
2000年 | 3篇 |
1999年 | 7篇 |
1998年 | 22篇 |
1997年 | 42篇 |
1996年 | 34篇 |
1995年 | 21篇 |
1994年 | 25篇 |
1993年 | 21篇 |
1992年 | 11篇 |
1991年 | 5篇 |
1990年 | 9篇 |
1989年 | 26篇 |
1988年 | 13篇 |
1987年 | 14篇 |
1986年 | 13篇 |
1985年 | 17篇 |
1984年 | 8篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1981年 | 4篇 |
1980年 | 6篇 |
1979年 | 7篇 |
1978年 | 6篇 |
1977年 | 14篇 |
1976年 | 8篇 |
1975年 | 5篇 |
1969年 | 2篇 |
1955年 | 1篇 |
1932年 | 1篇 |
排序方式: 共有664条查询结果,搜索用时 859 毫秒
131.
T. W. Custer D. W. Sparks S. A. Sobiech R. K. Hines M. J. Melancon 《Archives of environmental contamination and toxicology》1996,30(2):163-169
Farm-raised 12-month-old female mallards (Anas platyrhynchos) were released at the Winston-Thomas sewage treatment plant, Bloomington, Indiana. Five mallards were sacrificed at the start of the study and at approximately 10-day intervals through day 100. Concentrations of polychlorinated biphenyls (PCBs) in carcasses increased linearly with time of exposure and exceeded 16 g/g wet weight by day 100; PCBs in breast muscle exceeded 3.9 g/g by day 100. These PCB values are among the highest recorded for wild or sentinel waterfowl. PCB concentrations in breast muscle (26–523 g/g lipid weight) were 50–1,000 times greater than human consumption guidelines for edible poultry in Canada (0.5 g/g lipid weight) and 9–176 times greater than consumption guidelines for edible poultry in the United States (3.0 g/g lipid weight). Additionally, PCB concentrations in carcass and breast muscle exceeded the threshold of the Great Lakes Sport Fish Consumption Advisory do not eat category (1.9 g/g wet weight) by day 20 and day 50, respectively. Hepatic cytochrome P450-associated monooxygenases including BROD (benzyloxyresorufin-O-dealkylase), EROD (ethoxyresorufin-O-dealkylase), and PROD (pentoxyresorufin-O-dealkylase) were induced over 5-fold compared to reference mallards. BROD, EROD, and PROD were each significantly correlated to total PCBs and to the toxicity of selected PCB congeners, relative to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 相似文献
132.
Gadopentetate dimeglumine (gadolinium diethylenetriaminepentaacetic acid [DTPA]) was administered prospectively to 500 consecutive children and adults referred for routine cranial magnetic resonance (MR) imaging over a 4-month period. Pre- and postcontrast images were blindly and independently interpreted by two experienced neuroradiologists. Specific criteria were provided to the readers to define objectively when contrast material enhancement (or lack thereof) would be considered "radiologically helpful." Contrast-enhancing lesions were observed in 99 cases (20%). In only 15 cases (3%) did Gd-DTPA permit detection of lesions not also apparent on the precontrast studies. Contrast enhancement was considered radiologically helpful in 74 of the 99 cases. Lack of enhancement was considered helpful in 112 of the 500 cases (22%). Factors that may indicate increased usefulness of Gd-DTPA include increased patient age, definite lesion seen at computed tomography or precontrast MR imaging, prior craniotomy for tumor, and clinically documented systemic or central nervous system disease. Gd-DTPA should probably be used routinely for cranial MR imaging in most patients, except, perhaps, children and young adults with normal precontrast images. 相似文献
133.
134.
135.
136.
Nellie E Byun Michael Grannan Michael Bubser Robert L Barry Analisa Thompson John Rosanelli Raajaram Gowrishankar Nathaniel D Kelm Stephen Damon Thomas M Bridges Bruce J Melancon James C Tarr John T Brogan Malcolm J Avison Ariel Y Deutch Jürgen Wess Michael R Wood Craig W Lindsley John C Gore P Jeffrey Conn Carrie K Jones 《Neuropsychopharmacology》2014,39(7):1578-1593
Accumulating evidence suggests that selective M4 muscarinic acetylcholine receptor (mAChR) activators may offer a novel strategy for the treatment of psychosis. However, previous efforts to develop selective M4 activators were unsuccessful because of the lack of M4 mAChR subtype specificity and off-target muscarinic adverse effects. We recently developed VU0152100, a highly selective M4 positive allosteric modulator (PAM) that exerts central effects after systemic administration. We now report that VU0152100 dose-dependently reverses amphetamine-induced hyperlocomotion in rats and wild-type mice, but not in M4 KO mice. VU0152100 also blocks amphetamine-induced disruption of the acquisition of contextual fear conditioning and prepulse inhibition of the acoustic startle reflex. These effects were observed at doses that do not produce catalepsy or peripheral adverse effects associated with non-selective mAChR agonists. To further understand the effects of selective potentiation of M4 on region-specific brain activation, VU0152100 alone and in combination with amphetamine were evaluated using pharmacologic magnetic resonance imaging (phMRI). Key neural substrates of M4-mediated modulation of the amphetamine response included the nucleus accumbens (NAS), caudate-putamen (CP), hippocampus, and medial thalamus. Functional connectivity analysis of phMRI data, specifically assessing correlations in activation between regions, revealed several brain networks involved in the M4 modulation of amphetamine-induced brain activation, including the NAS and retrosplenial cortex with motor cortex, hippocampus, and medial thalamus. Using in vivo microdialysis, we found that VU0152100 reversed amphetamine-induced increases in extracellular dopamine levels in NAS and CP. The present data are consistent with an antipsychotic drug-like profile of activity for VU0152100. Taken together, these data support the development of selective M4 PAMs as a new approach to the treatment of psychosis and cognitive impairments associated with psychiatric disorders such as schizophrenia. 相似文献
137.
Erik Stites Dhiren Kumar Oyedolamu Olaitan Sidney John Swanson Nicolae Leca Matthew Weir Jonathan Bromberg Joseph Melancon Irfan Agha Hasan Fattah Tarek Alhamad Yasir Qazi Alexander Wiseman Gaurav Gupta 《American journal of transplantation》2020,20(9):2491-2498
The clinical importance of subclinical, early T cell–mediated rejection (Banff TCMR 1A and borderline lesions) remains unclear, due, in part to the fact that histologic lesions used to characterize early TCMR can be nonspecific. Donor‐derived cell‐free DNA (dd‐cfDNA) is an important molecular marker of active graft injury. Over a study period from June 2017 to May 2019, we assessed clinical outcomes in 79 patients diagnosed with TCMR 1A/borderline rejection across 11 US centers with a simultaneous measurement of dd‐cfDNA. Forty‐two patients had elevated dd‐cfDNA (≥0.5%) and 37 patients had low levels (<0.5%). Elevated levels of dd‐cfDNA predicted adverse clinical outcomes: among patients with elevated cfDNA, estimated glomerular filtration rate declined by 8.5% (interquartile rate [IQR] ?16.22% to ?1.39%) (?3.50 mL/min/1.73 m2 IQR ?8.00 to ?1.00) vs 0% (?4.92%, 4.76%) in low dd‐cfDNA patients (P = .004), de novo donor‐specific antibody formation was seen in 40% (17/42) vs 2.7% (P < .0001), and future or persistent rejection occurred in 9 of 42 patients (21.4%) vs 0% (P = .003). The use of dd‐cfDNA may complement the Banff classification and to risk stratify patients with borderline/TCMR 1A identified on biopsy. 相似文献
138.
139.
IntroductionTotal hip arthroplasty is one of the most commonly performed orthopaedic procedures. Despite this, medical evidence to inform the choice of surgical approach is lacking. Currently in the UK, the two most frequently performed approaches to the hip are the posterior and the direct lateral.MethodsThis systematic review was performed according to Cochrane guidelines following an extensive search for prospective controlled trials published in any language before January 2014. Of the 728 records identified from searches, 6 prospective studies (including 3 randomised controlled trials) involving 517 participants provided data towards this review.FindingsCompared with the lateral approach, the posterior approach conferred a significant reduction in the risk of Trendelenburg gait (odds ratio [OR]: 0.31, p=0.0002) and stem malposition (OR: 0.24, p=0.02), and a non-significant reduction in dislocation (OR: 0.37, p=0.16) and heterotopic ossification (OR: 0.41, p=0.13). Neither approach conferred a functional advantage. We draw attention to the paucity of evidence and the need for a further randomised trial. 相似文献
140.
AD White M Skelton F Mushtaq TW Pike M Mon-Williams JPA Lodge RM Wilkie 《Annals of the Royal College of Surgeons of England》2015,97(8):608-612